HMS Capital Management LLC lessened its position in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 7.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 5,756 shares of the company’s stock after selling 433 shares during the period. HMS Capital Management LLC’s holdings in HCA Healthcare were worth $1,728,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Terra Nova Asset Management LLC lifted its position in shares of HCA Healthcare by 0.3% in the third quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock worth $3,297,000 after buying an additional 26 shares during the last quarter. Waldron Private Wealth LLC increased its stake in HCA Healthcare by 1.8% during the third quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock valued at $683,000 after acquiring an additional 29 shares during the period. Integrated Advisors Network LLC increased its stake in HCA Healthcare by 0.6% during the third quarter. Integrated Advisors Network LLC now owns 5,132 shares of the company’s stock valued at $2,086,000 after acquiring an additional 31 shares during the period. BayBridge Capital Group LLC increased its stake in HCA Healthcare by 1.0% during the third quarter. BayBridge Capital Group LLC now owns 3,485 shares of the company’s stock valued at $1,416,000 after acquiring an additional 35 shares during the period. Finally, First Horizon Advisors Inc. grew its stake in shares of HCA Healthcare by 2.4% in the 3rd quarter. First Horizon Advisors Inc. now owns 1,532 shares of the company’s stock valued at $623,000 after purchasing an additional 36 shares during the period. Institutional investors own 62.73% of the company’s stock.
Analyst Upgrades and Downgrades
HCA has been the topic of several analyst reports. Truist Financial lowered their price objective on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Morgan Stanley decreased their price target on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research report on Tuesday, December 17th. TD Cowen decreased their price target on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. Oppenheimer increased their price target on HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a research report on Monday, October 28th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $405.00 price target on shares of HCA Healthcare in a research report on Monday, January 27th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $385.67.
HCA Healthcare Stock Down 3.5 %
Shares of NYSE:HCA opened at $312.55 on Thursday. The company has a market capitalization of $79.17 billion, a PE ratio of 14.23, a price-to-earnings-growth ratio of 1.11 and a beta of 1.64. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The company has a fifty day moving average of $313.49 and a 200-day moving average of $353.04. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08.
HCA Healthcare (NYSE:HCA – Get Free Report) last posted its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the prior year, the business earned $5.90 earnings per share. On average, equities analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.
HCA Healthcare Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be given a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.92%. The ex-dividend date of this dividend is Monday, March 17th. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio is 12.02%.
HCA Healthcare Company Profile
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Featured Stories
- Five stocks we like better than HCA Healthcare
- Best Stocks Under $10.00
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- The 3 Best Retail Stocks to Shop for in August
- Inflation Persists, But So Do Stock Opportunities: Rally On
- What Are Trending Stocks? Trending Stocks Explained
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.